Deccan Health Care Ltd (BSE: 542248) is a Hyderabad, Telangana-based company in the Vitamins and Nutritional Supplements industry. With a market capitalisation of ₹28 Cr, it ranks #4,193 by market cap among the 6,197 Indian listed companies on FinBizNet, and #4 of 5 in Vitamins and Nutritional Supplements. At ₹12.28 (as of 16 Nov 2026), the share price is 31.2% below its 52-week high of ₹17.85 and 84.7% above its 52-week low of ₹6.65. The share price is down 30.1% over one year and down 12.2% over three months.
| Current Price | ₹12.28 |
|---|---|
| Market Cap | ₹28 Cr |
| BSE Code | 542248 |
| Sector | Consumer Staples > Household and Personal Products > Personal Care Products |
| Sub-Industry | Personal Care Products > Vitamins and Nutritional Supplements |
| P/E Ratio | 11.9 |
| Return on Equity | 2.11% |
| Return on Assets | 1.65% |
| 52-Week Range | ₹6.65 – ₹17.85 |
| 1-Year Price Change | -30.1% |
| 3-Month Price Change | -12.2% |
| Beta (1Y) | 0.89 |
| Headquarters | Hyderabad, Telangana |
| Website | www.deccanhealthcare.co.in |
| Revenue | ₹22 Cr |
|---|---|
| Net Profit | ₹0 Cr |
| Net Margin | 1.1% |
| EPS (Basic) | ₹0.10 |
| Basis | standalone |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Deccan Health Care Ltd reported revenue of ₹22 Cr in Q1 FY27, up 1.8% from ₹21 Cr in Q1 FY26 and up 7.9% from ₹20 Cr in Q4 FY26. It posted a net profit of ₹0 Cr for the quarter, against a net profit of ₹0 Cr in Q1 FY26 (up 19.0%). Across the 8 quarters from Q2 FY25 to Q1 FY27, quarterly revenue ranged from ₹19 Cr (Q2 FY25) to ₹24 Cr (Q2 FY26). The company was profitable in each of these 8 quarters.
| Quarter | Revenue | Net Profit | Net Margin |
|---|---|---|---|
| Q1 FY27 | ₹22 Cr | ₹0 Cr | 1.1% |
| Q4 FY26 | ₹20 Cr | ₹0 Cr | 1.1% |
| Q3 FY26 | ₹23 Cr | ₹1 Cr | 4.1% |
| Q2 FY26 | ₹24 Cr | ₹1 Cr | 3.7% |
| Q1 FY26 | ₹21 Cr | ₹0 Cr | 1.0% |
| Q4 FY25 | ₹21 Cr | ₹0 Cr | 0.7% |
| Q3 FY25 | ₹20 Cr | ₹0 Cr | 0.8% |
| Q2 FY25 | ₹19 Cr | ₹1 Cr | 2.9% |
Standalone figures (₹ crore, XBRL filings).
Promoters held 56.25% of Deccan Health Care Ltd's shares as of Mar 2026, unchanged from Mar 2025. Delivery averaged 86.6% of traded volume across 15 BSE sessions (21 Oct 2026 – 13 Nov 2026).
Deccan Health Care Limited, a nutraceutical company provides nutritional, personal care, and food-based solutions. It produces and distributes soft gelatin capsules, food pills, vitamin supplements, and nutritional meals. The company also provides capsules, tablets, soft gels, powders, liquids, and gummies. Deccan Health Care Limited was incorporated in 1996 and is based in Hyderabad, India.
1. Manufacturing of Fast Moving Consumer Health Products (FMCHP)-This segment engages in manufacture and marketing a range of healthcare products, including nutraceutical, cosmeceutical, and ayurveda products.
1. Manufacturing of Nutraceutical Products-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Hexagon Nutrition Limited | ₹737 Cr | 19.4 | 16.26% | ₹110 Cr | — |
| Aayush Food And Herbs Ltd | ₹144 Cr | 36.4 | 38.75% | — | -67.8% |
| Sandu Pharmaceuticals Ltd. | ₹37 Cr | 20.7 | 4.13% | ₹16 Cr | -12.8% |
| Deccan Health Care Ltd | ₹28 Cr | 11.9 | 2.11% | ₹22 Cr | -30.1% |
| Walpar Nutritions Limited | ₹23 Cr | 9.2 | 13.93% | — | -47.4% |
Listed by market capitalisation. Ratios are shown for context only.
Deccan Health Care Ltd is trading at ₹12.28, with a market capitalisation of ₹28 Cr.
Deccan Health Care Ltd operates in the Consumer Staples > Household and Personal Products > Personal Care Products space (Personal Care Products > Vitamins and Nutritional Supplements).
Deccan Health Care Ltd has a P/E of 11.9 and a return on equity of 2.11%.
Deccan Health Care Ltd is listed on the BSE under the scrip code 542248.
Deccan Health Care Ltd's share price is down 30.1% over one year and down 12.2% over three months. Its 52-week range is ₹6.65 to ₹17.85.
In Q1 FY27, Deccan Health Care Ltd reported revenue of ₹22 Cr and net profit of ₹0 Cr, with basic EPS of ₹0.1 (standalone, parsed from the company's exchange filing).
Deccan Health Care Ltd reported revenue of ₹22 Cr in Q1 FY27, up 1.8% from ₹21 Cr in Q1 FY26 and up 7.9% from ₹20 Cr in Q4 FY26.
Promoters held 56.25% of Deccan Health Care Ltd's shares as of Mar 2026, unchanged from Mar 2025.
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.